Diagnostic Value of Combining Tumor and Inflammatory Biomarkers in Detecting Common Cancers in Korea.

CONCLUSIONS: Combining multiple tumor and systemic inflammatory biomarkers proved to be a valid strategy in the diagnosis of six common cancers in Korea. Further validation of appropriate screening populations through large-scale clinical trials are warranted.
PMID: 33577759 [PubMed - as supplied by publisher]

Source: International Journal of Clinical Chemistry - February 9, 2021 Category: Chemistry Authors: Sun Kim Y, Nam Kang K, Sung Shin Y, Eun Lee J, Young Jang J, Woo Kim C Tags: Clin Chim Acta Source Type: research